Chemical Structure : ACT001
货号: PC-23534Not For Human Use, Lab Use Only.
ACT001 (dimethylaminomicheliolide, DMAMCL) is a guaianolide sesquiterpene lactone that targets lasminogen activator inhibitor-1 (PAI-1), also is a a nuclear factor-κB (NF-κB) signaling pathway inhibitor and PKM2 activator, effectively inhibits the proliferation of both tamoxifen-sensitive and tamoxifen-resistant cells.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
ACT001 (dimethylaminomicheliolide, DMAMCL) is a guaianolide sesquiterpene lactone that targets lasminogen activator inhibitor-1 (PAI-1), also is a a nuclear factor-κB (NF-κB) signaling pathway inhibitor and PKM2 activator, effectively inhibits the proliferation of both tamoxifen-sensitive and tamoxifen-resistant cells.
ACT001 selectively activated PKM2 through covalent binding at residue cysteine 424 to promote tetramer formation.
ACT001 targets PAI-1 and inhibits glioma cell proliferation, invasion and metastasis through the PAI-1/PI3K/AKT pathway.
ACT001 can enhance the antitumour effects of cisplatin in vitro and in vivo.
分子量 | 279.38 | |
分子式 | C16H25NO3 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. Yu Q, et al. Eur J Pharmacol. 2024 May 15;971:176529.
2. Deng H, et al. Oncogenesis. 2023 Mar 30;12(1):19.
3. Jin XH, et al. J Cell Biochem. 2019 Feb;120(2):1386-1397.
4. Jaffar J, et al. Biomed Pharmacother. 2021 Jun;138:111471.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright